5.20
Becton, Dickinson and Company Selects JFK Communications for Diabetes Product Launch
BD Launch Leverages JFK Expertise in Medical Device Communications
Princeton, N.J., April XX, 2010 — JFK Communications is proud to announce that BD (Becton, Dickinson and Company) (NYSE:BDX), has selected the firm to provide public relations support to launch a new product for people with diabetes. The Franklin Lakes, N.J.-based medical technology company operates worldwide developing, manufacturing and selling medical devices, instrument systems and reagents. JFK will facilitate the product launch of BD’s new insulin delivery device and raise awareness of the importance of adherence to insulin therapy.
“Considering our current portfolio of medical device and diagnostics clients, working with BD is a strategic partnership for our firm,” said David Avitabile, President of JFK Communications. “We’re pleased for this opportunity to put our experience to work for such a well recognized leading global medical technology company.”
JFK‘s client roster also includes GE Healthcare Medical Diagnostics, Novo Nordisk, NicOx, PharmaNet Development Group and Tobira Therapeutics, among others.
JFK Communications, Inc. provides innovative public relations solutions for the pharmaceutical, biotechnology and medical technology industries. For more information about JFK Communications’ capabilities or career opportunities, please visit www.jfkhealth.com or call (609) 514-5117.
###